nr |
titel |
auteur |
tijdschrift |
jaar |
jaarg. |
afl. |
pagina('s) |
type |
1 |
An intersectional analysis of sociodemographic disparities in Covid-19 vaccination: A nationwide register-based study in Sweden
|
Spetz, M. |
|
|
40 |
46 |
p. 6640-6648 |
artikel |
2 |
Association of culturally competent care with influenza vaccination coverage in the United States
|
Paguio, Joseph Alexander |
|
|
40 |
46 |
p. 6607-6615 |
artikel |
3 |
Counselling of non-communicable diseases’ patients for COVID-19 vaccine uptake in Jordan: Evaluating the intervention
|
Al-Shaikh, Ala'a |
|
|
40 |
46 |
p. 6658-6663 |
artikel |
4 |
COVID-19 outbreak in an elderly care home: Very low vaccine effectiveness and late impact of booster vaccination campaign
|
van Ewijk, Catharina E. |
|
|
40 |
46 |
p. 6664-6669 |
artikel |
5 |
COVID-19 vaccine perceptions and hesitancy amongst parents of school-aged children during the pediatric vaccine rollout
|
Byrne, Alexandra |
|
|
40 |
46 |
p. 6680-6687 |
artikel |
6 |
Editorial Board/Aims and Scope
|
|
|
|
40 |
46 |
p. IFC |
artikel |
7 |
Effectiveness of maternal pertussis vaccination in Singapore: A test-negative case-control study
|
Chong, Chia-Yin |
|
|
40 |
46 |
p. 6570-6574 |
artikel |
8 |
Effectiveness of the 23-valent pneumococcal polysaccharide vaccine against community-acquired pneumonia in older individuals after the introduction of childhood 13-valent pneumococcal conjugate vaccine: A multicenter hospital-based case-control study in Japan
|
Nakashima, Kei |
|
|
40 |
46 |
p. 6589-6598 |
artikel |
9 |
Immunogenicity of rVSVΔG-ZEBOV-GP Ebola vaccine (ERVEBO®) in African clinical trial participants by age, sex, and baseline GP-ELISA titer: A post hoc analysis of three Phase 2/3 trials
|
Simon, Jakub K. |
|
|
40 |
46 |
p. 6599-6606 |
artikel |
10 |
Increasing seroprevalence but waning herd immunity against measles after elimination: Longitudinal seroepidemiology of measles in Osaka Prefecture, Japan, 2003–2020
|
Kurata, Takako |
|
|
40 |
46 |
p. 6581-6588 |
artikel |
11 |
Individual-level factors associated with COVID-19 vaccine acceptance among U.S. patients with cancer
|
Hathaway, Cassandra A. |
|
|
40 |
46 |
p. 6649-6657 |
artikel |
12 |
Modelling optimal vaccination strategies against COVID-19 in a context of Gamma variant predominance in Brazil
|
Ferreira, Leonardo Souto |
|
|
40 |
46 |
p. 6616-6624 |
artikel |
13 |
Pilot study to determine effect of an altruism intervention focusing on herd immunity to enhance influenza vaccination rates
|
Marlowe, Elizabeth |
|
|
40 |
46 |
p. 6625-6630 |
artikel |
14 |
Predicting the long-term impact of rotavirus vaccination in 112 countries from 2006 to 2034: A transmission modeling analysis
|
Kraay, A.N.M. |
|
|
40 |
46 |
p. 6631-6639 |
artikel |
15 |
Shades of doubt: Measuring and classifying vaccination confidence in Europe
|
Rughiniș, Cosima |
|
|
40 |
46 |
p. 6670-6679 |
artikel |
16 |
Trends in HPV vaccine administration and HPV vaccine coverage in children by race/ethnicity and socioeconomic status during the COVID-19 pandemic in an integrated health care system in California
|
Chao, Chun R. |
|
|
40 |
46 |
p. 6575-6580 |
artikel |
17 |
With established safe and effective use, protein vaccines offer another choice against COVID-19
|
Marchese, Anthony M. |
|
|
40 |
46 |
p. 6567-6569 |
artikel |